Results 51 to 60 of about 559,312 (314)
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Optimization of Magnetic Cobalt Ferrite Nanoparticles for Magnetic Heating Applications in Biomedical Technology. [PDF]
Zahn D +8 more
europepmc +1 more source
“What if There's Something Wrong with Her?”‐How Biomedical Technologies Contribute to Epistemic Injustice in Healthcare [PDF]
Joel Michael Reynolds
openalex +1 more source
Adoption of Digital Pen and Paper Technology (DPP) in Biomedical Technology [PDF]
Dimitrios Zarakovitis
openalex +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Dysthanasia in medicine is the artificial prolongation and delay of death in a terminal patient, using all available means. With the advancement of sophisticated medical technologies and care, the patient can be kept alive as long as possible in the ...
Greš Alen +2 more
doaj +1 more source
Microalgae in Terms of Biomedical Technology: Probiotics, Prebiotics, and Metabiotics. [PDF]
Oleskin AV, Boyang C.
europepmc +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Gabriel André da Silva Mendes,1,2 Cintya Yukie Hayashi,2,3 Gustavo Henrique Frigieri Vilela,3 Lissa Kido,3 Manoel Jacobsen Teixeira,2 Fernando Campos Gomes Pinto2 1Physiotherapy Nucleous, Hospital of the State Public Servant of São Paulo, São Paulo City,
Mendes GAS +5 more
doaj

